The prevalence of insomnia is greater in end-stage renal disease. The aim of our study was to determine the frequency of insomnia and subclinical insomnia in patients with various dialysis therapy and kidney transplant recipients, in order to assess the severity of insomnia and examine whether there is a difference in severity among groups. In cross-sectional study, we evaluated 120 patients with terminal renal failure. Based on therapy, patients were divided into four groups: hemodiafiltration, standard bicarbonate dialysis, peritoneal dialysis and kidney transplant recipients. The severity of insomnia was evaluated through the use of the Insomnia Severity Index (ISI). Most patients who reported any kind of insomnia problems with ISI were on conventional dialysis (80%), followed by hemodiafiltration (76.7%) and peritoneal dialysis (63.3%). Transplant recipients had least difficulties with insomnia (46.7%). Insomnia Severity Index showed that insomnia in end-stage renal patients is not very severe. Most of the patients had "no clinically significant insomnia". Our findings indicate that patients on hemodiafiltration and transplant recipients have a significantly lower score on Insomnia Severity Index. Patients with end-stage renal disease have high frequency insomnia problems. However, our study shows that insomnia in these patients is not severe. Insomnia is the most frequent and severest in patients on standard bicarbonate dialysis.
Introduction
Insomnia is characterized by: trouble falling asleep, maintaining sleep, or non refreshing sleep. Disturbances in sleep occur at least three times per week for at least one month; sleep disturbance results in marked personal distress or interference with personal functioning in daily living [1] .
The prevalence of insomnia is greater in dialysis patients than in general population [2, 3] . Studies have been reported to range from 45% to 90% [4] [5] [6] [7] [8] [9] [10] [11] . Insomnia occurs at an early stage chronic kidney disease (CKD), too [12, 13] . Its frequency in early CKD is 62.9% [12] . Much less information is available about the prevalence of insomnia in transplant patients [14, 15] .
Researches suggest that insomnia has an effect on physical, mental and social functions [16, 17] . "Poor sleep" in dialysis patients is associated with lower quality of life [8, 18, 19] . Also there is no study that examines the severity of insomnia in patients with various dialysis therapy and kidney transplant recipients.
The aim of our study was to determine the frequency of insomnia and subclinical insomnia in patients on hemodiafiltration (HDF), bicarbonate hemodialysis (BHD), peritoneal dialysis (PD) and transplant kidney recipients, to assess the severity of insomnia by Insomnia Severity Index (ISI) and examine whether there is a difference among groups in severity. We also examined what kind of insomnia is the most common in these groups (initial, transitory, terminal or mixed).
Materials and methods

Subjects
Our observation cross-sectional study was conducted between December 2010 and January 2011 at the Clinic of Nephrology, Clinical centre Nis. We evaluated 120 patients with chronic renal failure. Patients were divided into four groups: hemodiafiltration (group 1), patients on standard bicarbonate dialysis (group 2), peritoneal dialysis (group 3) and kidney transplant recipients (group 4). All patients who were receiving dialysis therapy or whose health conditions were regularly monitored during the mentioned period participated in the research. The study was approved by the local Ethics Committee. The criteria for including patients in the study were: age >18 years, without communication barrier and provided informed consent. All patients in our study were stabile dialysis/ transplant patients without significant comorbidity. We excluded patients with psychiatric disorders and cognitive dysfunctions.
BHD patients were treated three times weekly, about 4.5 hours per session. HDF patients were treated three times weekly as well, for about 4.5 hours per session. PD was done as CAPD (continuous ambulatory peritoneal dialysis). All HD patients were in daily shifts and had adequate dialysis (Kt/V > 1.2).
Insomnia Severity Index (ISI). The Insomnia Severity Index has seven questions which demonstrate following issues in patients: the severity of their problem with falling asleep, staying asleep, waking up too early, satisfaction with their current sleep pattern, how much the patients' sleep problems are noticeable to others, how much the patients are worried about their current sleep problem and whether these problems influence their daily functioning. Each question score ranged from 0 to 4. The seven answers are added up to get a total score. A higher score indicates severe insomnia. The ISI is a reliable and valid instrument to quantify perceived insomnia severity [20] .
Statistical methods
Data were expressed as mean ± standard deviation and frequency (%). The Kolmogorov-Smirnov test was used for testing variable's normality. After we had given nonnormally distributed variables the statistical significance among the study groups was assessed by using the nonparametric Kruskal-Wallis Test (three or more categories) and Mann-Whitney Tests (two categories). Chi-square test was applied to compare percentage. Linear regression analysis was used to determine factors affecting ISI. Analyses were performed using SPSS, version 13.0. P-value ≤ 0.05 was considered statistically significant.
Results
We evaluated 120 patients (74 males and 46 females) who were divided into four groups: hemodiafiltration (HDF), patients on standard bicarbonate dialysis (BHD), peritoneal dialysis (PD) and kidney transplant recipients. Sociodemographic and clinical characteristics of the patients included in the study are present in Table 1 . As shown in table, there were no statistically significant differences in gender, marital status, educational status, employment status, economic status, lifestyle characteristics (smoking and alcohol intake), diabetes and duration of the therapy among groups. The mean duration of time on therapy was: 47.2 ± 50.0 (HDF), 30.9 ± 31.5 (BHD), 35.3 ± 27.5 (PD) and 30.9 ± 37.9 (transplantation) months. The time on therapy in transplant group relates to transplantation period (no total replacement therapy period). We found statistically significant difference among groups regarding age and presence of ischemic hearth disease.
Most patients who reported any kind of insomnia symptoms with ISI were on BHD (80%), then HDF (76.7%) and PD (63.3%). Transplantation recipients had least difficulties with insomnia (46.7%) (Figure1). Insomnia symptoms were considered to be: difficulty falling asleep, difficulty staying asleep and problems with waking up too early. The most frequently recorded type of insomnia problem was mixed night-time waking, trouble falling asleep and early morning waking ( Table 2 ). The total score ISI showed that most patients have "no clinically significant insomnia" ( Table 3) .
Kruskal-Wallis Test indicated statistically significant differences in insomnia severity among the study groups (p=0.040). Additional Mann-Whitney tests found statistically significance difference in insomnia severity between BHD and HDF (p=0.002) and between BHD and transplant recipients (p=0.048) ( Table 4 ).
The ischemic hearth disease is significantly and independently associated with insomnia severity index ( Table 5 ). There was no significantly association between insomnia severity score and age, smoking, alcohol intake and diabetes.
Discussion
We compared socioeconomic conditions among the groups in order to eliminate differences of socioeconomic factors among the groups which can have influence on the severity of insomnia. Except in age and presence of ischemic hearth disease, there is no statistical significant difference in other sociodemographic and clinical characteristics among groups. The mean age of patients was: 56.4 ± 11.1 (HDF), 54.5 ± 16.4 (BHD), 56.1 ± 13.1 (PD) and 41.3 ± 7.7 (transplantation). Patients in standard bicarbonate dialysis, hemodiafiltration and peritoneal dialysis have approximately the same age, but transplant patient are younger. It is because kidney donation typically occurs in younger chronic renal failure patients. In our patients it is the most common living donation between relatives. Frequency of ischemic hearth disease is the lowest in transplant patients which is according to expectations, because they are the youngest.
Insomnia is a great problem in end-stage renal patients. The prevalence of insomnia in these patients ranges widely in various studies. This is most likely due to different diagnostic criteria [1, 21] and certain limitations of using subjective tests in detecting sleep problems [22] . Patients in our study reported high frequency insomnia problems. Values obtained correspond with the results of previous researches [5, 7, 9, 10, 23, 24] . However, the main aim of our study was to assess whether there is a difference in frequency and severity of insomnia among various dialysis therapies.
Patients from all groups complained about difficulty falling asleep, difficulty staying asleep and early morning waking, but most had a mixture of problems. Night-time waking and difficulty falling asleep were reported mostly. These data match the reports of previous studies [11] .
The fact is that there are many studies of the prevalence of insomnia, but there are almost no studies that examine the severity of insomnia in end-stage renal patients. Therefore, this is the first study that has attempted to determine how clinically significant these insomnia problems, which the patients without doubt have, really are. The results we obtained using a questionnaire Insomnia Severity Index show that insomnia in end-stage renal patients is not very severe (Table 3) .
Previous researches have shown that the psychological and physical cases contribute to insomnia in end-stage renal disease patients. Insomnia correlated with the presence of depression, anxiety, anemia, primary sleep disorders such as restless legs syndrome, metabolic [23, 25] and immunology distress [26] . It is questionable how dialysis therapy influences, directly or indirectly (through the co-morbidites state), the onset of insomnia in these patients.
While some studies found a connection between insomnia and biochemical parameters of dialysis efficiency [6, 23] , others don't [27] . The main finding of this study is that patients in BHD have a higher rate of insomnia symptoms than patients in HDF. The frequency and severity of insomnia is slightly higher in BHD patients than in HDF patients. This result was partly known [9] and expected because HDF treatment reflects an improved blood clearance on uremic toxins.
The lowest frequency and severity of insomnia was found in kidney transplant recipients. Such a result is in agreement with those in other studies [15, 28, 29] . Sabatini et al. compared data obtained from 301 kidney transplant patients with data from patients on maintenance dialysis using Pittsburg Sleep Quality Index (PSQI). The PSQI score of the transplant patients was significantly lower, indicating better overall sleep quality than in patients on maintenance dialysis [15] .
The relationship between age and sleep quality is controversial in chronic renal failure patients [6, 7, 10, 24] . The prevalence of insomnia increases with age. In this study we didn't observe relation between prevalence of insomnia and age, we observed relation between the severity score of insomnia and age. There was no significant association. Some investigations reported that smoking and alcohol intake can be associated with sleep disorders [8] , while other studies found no significant association [10, 23, 24] . In our study, we also found that these habits did not contribute to the insomnia severity score. A few studies have suggested that number and severity of comorbidity in hemodialysis patients can be attributed with the increase in the prevalence of sleep disorders [2, 4, 30] . In our study, we found that ischemic hearth disease was an independent determinant of the insomnia severity score.
Potential limitation of the questionnaire which was used in this study must also be taken into consideration. For more precise examining of the frequency of insomnia, some other questionnaires should be used. Despite these limitations this study noted some differences in the severity of insomnia problems in chronic renal disease patients on various renal replacement therapies, which was our primary goal.
What should be examined is how specific parameters of dialysis influence insomnia problems in dialysis patients.
Conclusion
Patients with end-stage renal disease have high frequency insomnia problems. However, our study shows that insomnia in these patients is not severe. There are statistically significant differences in the severity of insomnia between patients on hemodiafiltration and standard bicarbonate dialysis and between patients on standard bicarbonate dialysis and kidney transplant recipients.
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